Diabetic Retinopathy
Blurry vision due to diabetes is known as diabetic retinopathy, which represents the ocular manifestation of end-organ damage in diabetes mellitus 1.
Understanding the Condition
Diabetic retinopathy is the common complication affecting vision in both type 1 and type 2 diabetes. The blurry vision occurs through several mechanisms 1:
- Retinal thickening (edema) from increased vascular permeability
- Hard exudates (lipid deposits) in or near the macula
- Capillary nonperfusion causing retinal ischemia
- Vitreous hemorrhage from proliferative changes
- Traction retinal detachment in advanced stages
Clinical Stages That Cause Vision Loss
The progression follows a predictable pattern 1:
Nonproliferative Stage
- Microaneurysms and intraretinal hemorrhages
- Cotton wool spots and venous abnormalities
- Diabetic macular edema (DME) - the primary cause of blurry vision in early disease
- When edema involves the center of the macula, vision loss occurs
Proliferative Stage (PDR)
- Neovascularization on the disc and retina
- Vitreous hemorrhage causing sudden vision loss
- Fibrous proliferation leading to retinal detachment
- Neovascular glaucoma from iris neovascularization
Important Clinical Distinction
While "diabetic retinopathy" is the overarching term, the specific cause of blurry vision depends on which component is present 1:
- Diabetic macular edema (DME) causes gradual central vision blur
- Vitreous hemorrhage causes sudden vision loss
- Retinal detachment causes progressive visual field loss
Screening Requirements
Type 1 diabetes: Begin annual screening 5 years after diagnosis 1
Type 2 diabetes: Screen immediately at diagnosis, then at least yearly 1
The guidelines emphasize that only 60% of diabetic patients receive recommended yearly screenings, representing a critical gap in care 1. Referral to an ophthalmologist is required when any evidence of diabetic retinopathy is detected 1.
Prevention Through Metabolic Control
Maintaining tight control of glucose (HbA1c) and blood pressure directly reduces the risk of retinopathy development and progression 1. This represents the most effective preventive strategy, as demonstrated by landmark trials including the DCCT and UKPDS 1.